Business

Are Social Equity Cannabis Rules a Corporate Strategy to Monopolize the Marijuana Industry?

Published

3 years ago

August 2, 2022

Why Social Equity Cannabis Legalization is a Corporate Strategy to Monopolize the Cannabis Market

I am always very weary when it comes to “Social Equity” and policies like “Affirmative Action”. Not because I don’t believe that we need to create systems that empower the individual to rise above their current situations – but because for the most part the “social equity” card has been utilized by corporations to dodge responsibility while “seeming” to be working for a greater good.

For example, the “Climate Change” argument detracts from the real culprits that are destroying our earth; MONSTER CORPORATION AND GLOBAL ARMIES.

That’s right, most of the pollution that massively affect the planet comes from the very corporations pushing green agendas. They fly in their private jets to far off lands to talk about how they can “save the world”.

That level of sadistic psychopathy can only be mastered by the ruling elite and what’s worse is that they believe that everybody will simply “go along with it”.

The scary thing is that at the very least there is some portion of the population who do blindly go along with these policies.

However, today we’re not here to talk about the flaws of Climate Change, but rather, we’re taking a closer look at another “hype term” – Social Equity.

Dafuq is Social Equity?

You may have heard the term “Social Equity” thrown around with cannabis legalization bills, workplace policy and so forth. So for the sake to end all doubts, let’s take a closer look at the definition of “Social Equity”.

According to Knowledge Bank,

Social Equity, at its simplest, can be understood as impartiality, fairness, and justice for all people.1 This means taking into account systemic inequalities to ensure that that everyone has access to the same opportunities and outcomes.

In other words, it’s a retroactive system that attempts to “level the playing field” in a number of ways whether through affirmative action, and creating “special rules” for the marginalized or restricting other people from engaging with a particular activity.

Now, before some of you go ballistic and break down the concept of “Social Equity”, it isn’t necessarily coming from a “bad place”.

After all, in an ethical and open society, we would want to ensure that everybody in a legal sense is treated equally.

THE PROBLEM with social equity comes in relation to one of its core motivations – that everyone has access to the same opportunities and outcomes.

While in an ideal world, this would be a nice scenario. Everyone has access to the same opportunities and outcomes. The problem is that no outcome, even if you get all the help from the government, is guaranteed.

In relation to “opportunities”, by definition every individual has their own advantages and disadvantages. For example, if Candidate A, B and C all work in the exact same position at their job but Candidate A is a single person in good health, Candidate B is a single mother barely making it each week, and Candidate C is a person with a physical disability – they all might have the same opportunities, but their outcomes will differ significantly.

This is because you can’t engineer the outcome. You can only provide the opportunity.

This is the core issue with social equity – trying to engineer an artificial outcome. And this is exactly why the whole social equity experiment in cannabis isn’t working out.

What’s more, it seems that the only real people benefiting from these “social equity licenses” are monster corporations who are supposed to not have access to these licenses.

What’s happening in Arizona?

In Arizona, they have such a scheme where people with prior marijuana convictions can get access to Equity licenses. Essentially, this is the state’s attempt to undo the damage of the drug war. While this is a nice gesture, the biggest problem for people who have a state or federal marijuana record is that – they typically don’t have any funds.

Since starting up a successful cannabis venture requires a lot of money. And so, big firms are searching for people who can essentially “partner” with them for access to the equity licenses, and in turn, everybody wins!

Well – at first!

Then, after a while, the firm can buy out the license and keep it under the name holder, add it to their portfolio, and essentially muscle out the affected communities!

And why wouldn’t you do that. The state has this entire scheme of licenses that can’t really be touched by the affected community due to their lack of financing. Even if they got financing as well, it’s very different to run a successful cannabis business than selling weed out of the trunk of your car.

Having a marijuana conviction doesn’t immediately make you an expert in selling marijuana in a legal environment. In fact, one would argue that having a marijuana conviction indicates that you were impoverished enough that risking your freedom for the promise of money was “worth it”.

These aren’t the type of people who necessarily can run a dispensary, check payroll, pay the lights, taxes, etc.

Therefore, it makes sense that corporations want to jump in, float the hefty bill of running the place, and then siphon off money from these equity licensing for years to come.

This is why a new civil lawsuit is being issued against the state of Arizona by an advocacy group who claim the state have failed to protect these minority communities from corporate overreach.

The new legal complaint argues that the social equity program has failed to meet the standards laid out in Prop 207, the ballot initiative voters passed last year that legalized marijuana and has allowed thousands of Arizonans to expunge prior marijuana charges. Through Prop 207, voters directed the state to create a program that promoted dispensary ownership by people who were disproportionately impacted by marijuana laws — which, in Arizona, often was poor, Black and Latino communities.

But since the draft rules for the social equity program were released, advocates warned that major cannabis investors might easily game the system. And now, Rodriguez says that’s what she’s seeing.

“What the voters were trying to do was enrich communities that were impacted by the drug war.” Jimmy Cool, the lead attorney on the case, told New Times. “From our clients’ perspective, all [the program] does is enrich 26 people.” – SOURCE

And that’s the truth with virtually all of these schemes.

Why Social Equity fails!

It’s easy for a millionaire to sit down, analyze the problems of the poor and say, “Do this and you’ll achieve that!” The problem with the millionaire is that he or she does not share the same values, needs, and desires as that as a poor person.

Therefore, “thinking” from the perspective of an affluent individual can never understand the nuances needed for the affected to truly succeed. The Social Equity licensing is a solution produced by the affluent to whitewash their “drug war” guilt.

It’s an invention by woke-corporatism to show they care, when in reality they profited off the war on drugs and will profit on the legalization of drugs too.

The main problem with Social Equity is;

Limited licenses creates artificial value
The costs associated with cannabis is still high
You still need corporate to run a cannabis store

Since costs are so exuberant, it’s impossible for someone who spent years in jail to raise capital. Without access to banking loans, or even the experience of running a successful business – the only solution to these “equity license” holders are to partner with some money-hungry firm.

The solution is a 2-Tier Cannabis Industry

I have said this once, and I’ll say this again. The ONLY real solution is to create a distinction between corporate cannabis, and “mom and pop” operations.

The biggest problem with the lower strata of society is that the fees associated with the cannabis industry reflect the budgets of big corporations, while the rest of us are working on Farmer’s Market budgets.

Which is why we need to create a system that allows people of the lower income bracket to be able to build a business without needing too much investment. We can also reduce the burden on these businesses by reducing the strictness on testing, etc.

My plan has always been;

$1000 for a yearly license for cannabis operations earning up to $1,000,000 in profits annually. Once the $1,000,000 thresh hold is met, then the corporate cannabis scheme can come into play.

This gives people the opportunity to be able to grow a business from the ground up. What this will also mean is that there would be no “Equity licenses”. Anybody would be able to get it for $1,000.

If you can’t get $1k together, you might not deserve a cannabis license.

This also gives these equity license holders the opportunity to grow a business from the ground up, hire local talent, and undo the damages of the drug war.

Yet, we must first separate the need to add in social equity into every bill, because before you know it – the corporations will gobble up all those licenses and then we’re all screwed.

Final Words

There’s a reason why Schumer hasn’t been able to pass any cannabis legislation. It’s because of these social equity laws. While it’s nice to think about those effected by the Drug War, unless you bring actual solutions that can be scaled by the affected demographic – you’re just making up millionaire solutions to the impoverished who can never attain the standards set by the elite.

Reduce legalization to what it is; a plant that needs to be cultivated, processed and sold, There needs to be no social equity written into the core of legalization.

Rather, each state could create investment clubs via taxation, however – understanding the nature of politics…unless we push back and remove their social equity language from the legalization efforts – the Arizona dilemma will only continue everywhere else in the US.

Make weed legal, make it cheap to get involved, and allow these small businesses a grace period to grow. And you’ll see the net benefit would far outweigh social equity laws.

Source: https://cannabis.net/blog/opinion/are-social-equity-cannabis-rules-a-corporate-strategy-to-monopolize-the-marijuana-industry

Aviation

IndiGo Crisis Exposes Risks of Monopoly: What If Telecom or E-commerce Collapses Next?

Published

2 months ago

December 7, 2025

Jon Tru

Airports across India witnessed scenes of distress and confusion as thousands of passengers were stranded due to IndiGo’s massive flight disruptions. Families with medical emergencies, funerals, and personal crises were left helpless as the airline cancelled hundreds of flights without adequate communication or support.

Passengers described desperate situations — a mother pleading for sanitary pads for her daughter, a woman unable to transport her husband’s coffin, and others stranded while trying to reach family funerals or hospitals. “It was like a lockdown at the airport,” one passenger said, describing the panic that unfolded as IndiGo’s mismanagement crippled operations nationwide.

Root Cause: IndiGo’s Market Monopoly

The turmoil, industry experts argue, stems from IndiGo’s monopolistic control over India’s domestic aviation market. The airline operates nearly 2,100 flights daily and holds around 60% market share — meaning every second plane flying within India belongs to IndiGo.

This dominance has given the company unparalleled influence. When IndiGo falters, the entire aviation system suffers. Passengers are left with few alternatives, as other airlines lack capacity to absorb stranded travellers. The result: skyrocketing ticket prices, chaos at terminals, and total dependence on a single private operator.

Aviation pioneer Captain G.R. Gopinath, founder of Air Deccan, criticised the government’s inaction, noting that on some routes, IndiGo’s economy fares surged to ₹1 lakh. He compared the situation to a hostage crisis, writing that the airline “held the system ransom” and forced regulators to defer new safety rules meant to protect pilots and passengers.

Government Intervention and Regulatory Weakness

The crisis erupted after IndiGo failed to comply with the Flight Duty Time Limitations (FDTL) — rules introduced by the DGCA in January 2024 requiring adequate rest for pilots. Despite having nearly two years to adapt, IndiGo blamed the rule for operational disruptions, citing a shortage of pilots.

Under mounting public pressure, the government stepped in, temporarily relaxing FDTL norms and capping airfare hikes. Officials claimed the move was to protect passengers, but analysts say it exposed the state’s vulnerability to corporate monopolies. “The government had no option but to yield,” said one aviation policy expert, pointing out that ignoring safety regulations for short-term relief could have long-term consequences.

The crisis also rekindled memories of the June 2025 Air India crash near London, which claimed over 240 lives. Experts warn that compromising pilot rest and safety standards to maintain flight schedules could risk another tragedy.

If Telecom Giants Fail: A National Paralysis

The article raises a troubling question — what if a similar crisis struck the telecom sector, where Jio and Airtel together control nearly 80% of subscribers and serve over 780 million users?

If both networks failed simultaneously, the repercussions would be catastrophic. Internet shutdowns would halt UPI transactions, online banking, OTP verifications, video calls, OTT streaming, and emergency communications. Critical services such as airports, hospitals, stock exchanges, and small businesses — many of which rely on WhatsApp and digital payments — would come to a standstill.

In essence, a telecom breakdown could paralyse India’s digital economy, exposing the nation’s dependence on a duopoly.

E-commerce Monopoly: Another Fragile Ecosystem

The same risk looms over the e-commerce sector, where Amazon and Flipkart dominate nearly 80% of the market. A disruption similar to IndiGo’s could cripple daily life — halting delivery of groceries, medicines, and essential goods, freezing refunds and customer support, and leaving small sellers without platforms to trade.

Local retailers, freed from competition, might exploit shortages by inflating prices. Such a scenario underscores the perils of market centralisation in sectors critical to everyday living.

A Wake-Up Call for Regulators

The IndiGo crisis, analysts say, is a warning shot for policymakers and regulators. A single company’s operational failure exposed systemic weaknesses in India’s infrastructure and consumer protection mechanisms.

As the aviation regulator DGCA investigates and IndiGo works to restore normalcy, the broader lesson remains clear: unchecked monopoly power in any essential service — whether air travel, telecom, or e-commerce — poses a direct threat to economic stability and citizen welfare.

Without stronger competition laws, redundancy frameworks, and regulatory oversight, India risks repeating this crisis across multiple sectors — each time with millions of citizens paying the price.

Agriculture & Life Sciences

Canada’s Cannabis Industry Urges Government to Support Growing Export Market

Published

2 months ago

November 24, 2025

Jon Tru

BuzzBuzz Cannabis Business News — 24 November 2025

Canada’s cannabis sector is calling on federal and provincial governments to recognize its fast-growing export potential and extend the same support other regulated industries receive. Industry leaders warn that Canada is losing its early global advantage due to slow regulatory processes, lack of trade promotion, and limited access to government-backed financing.

Canada’s medical-cannabis exporters now generate more than half a billion dollars annually and ship products to major markets including Germany, the UK, Australia, and Poland. Despite this, cannabis remains largely absent from Canada’s official trade and export strategies.

Industry Calls for Streamlined Export System

Paul McCarthy, President of the Cannabis Council of Canada, says the country has everything required to dominate the global medical cannabis trade—except government alignment.

“Our requests are simple,” McCarthy said. “Expedite Health Canada’s export-permit process, integrate cannabis into federal export programs like Global Affairs Canada trade missions and CanExport, and ensure provinces include cannabis in their export strategies.”

He stressed the need for mutual recognition agreements with importing countries to eliminate redundant testing and documentation. Access to Export Development Canada (EDC) and Business Development Bank of Canada (BDC) services also remains off-limits to cannabis exporters, placing them at a steep disadvantage.

“This industry does not just need permission to operate,” McCarthy added. “It needs to be treated like every other legitimate contributor to Canada’s trade objectives.”

Competitors Are Moving Faster

McCarthy warns that while Canada pioneered medical cannabis standards, other countries are rapidly advancing with more flexible and export-friendly systems.

“Faster approvals, lower compliance costs, and active government-backed strategies are helping other nations catch up,” he said. “Canada’s regulatory friction is already costing us global market share.”

Export permits currently must be issued for each shipment—a process that can take weeks—and Canadian testing standards often differ from international requirements, forcing companies to repeat expensive compliance checks.

High Tide CEO: Canada Needs a National Export Strategy

Raj Grover, CEO of High Tide Inc., says Canada risks surrendering its leadership if policymakers remain inactive.

“Canada developed the world’s most advanced cannabis regulatory system and contributed $76.5 billion to GDP since legalization,” Grover said. “But without a National Cannabis Export Strategy, we will lose ground to Australia, Israel, Portugal, and other emerging competitors.”

He noted that Canada’s industry table created by Innovation, Science and Economic Development Canada (ISED) has not met in more than a year—an opportunity wasted.

Grover urged the federal government to introduce domestic GMP certification and potency standards to streamline international market access. “Canadian producers must currently get GMP approval country by country. It’s duplicative and costly. Canada should be setting global benchmarks, not chasing them.”

Germany: A Key Market for Canadian Firms

High Tide recently expanded into Europe with its majority acquisition of Germany’s Remexian Pharma GmbH, giving the company a direct import and distribution channel in Europe’s largest medical-cannabis market.

“Our German strategy is already structured for success,” Grover said. “Through Remexian, we can supply premium medical cannabis at the lowest possible price, helping meet Germany’s quality and cost demands.”

Grover also warned that U.S. companies are already purchasing Canadian firms to stage their own international expansion—another sign that Canada’s leadership position is slipping.

Government Response Remains Limited

In response to industry concerns, a Global Affairs Canada spokesperson said the Trade Commissioner Service “continues to support exporters of cannabis for medical and scientific purposes that have obtained Health Canada permits.”

However, industry leaders argue that this support is minimal and does not include key tools such as trade missions, export credits, or bilateral agreements that other sectors routinely receive.

A Closing Window of Opportunity

With medical-cannabis exports already exceeding $500 million annually, industry executives say Canada must act quickly to preserve its competitive edge.

As McCarthy warns, without coordinated government support, Canada risks losing high-value pharmaceutical manufacturing, research investments, and thousands of skilled jobs.

And as Grover’s expansion into Germany demonstrates, the industry is moving forward—but whether Canada moves with it may determine if the country remains a global leader or becomes a pioneer that let others capitalize on its breakthroughs.

Business

A Tipping Point for Cannabis: President Trump Champions CBD & Cannabis Science on Truth Social

Published

2 months ago

November 16, 2025

Jon Tru

When the President of the United States shares a video about the life changing potential of hemp derived CBD on his personal social media platform, it is more than news, it is a cultural shift.

For decades our government lied to us about cannabis. It demonized the plant, waged war on its users, and filled prisons while allowing pharmaceutical companies to flood the nation with addictive and deadly drugs. For over a century we have been fighting uphill, not just for legalization, but for truth, for science, and for the right to heal ourselves naturally.

Now in 2025, the most powerful political figure on Earth is using his own voice and platform to talk about the endocannabinoid system and the science backed benefits of CBD. That is monumental. It is validation for everyone who has fought, been arrested, been silenced, and been dismissed for telling this truth. The President’s video post is already being described as a pivotal moment in cannabis history, and President Trump CBD Cannabis Science Truth Social is trending across platforms as advocates celebrate the breakthrough.

The Science Behind the Endocannabinoid System

The video begins by introducing something most people, including many doctors, still know little about, the endocannabinoid system. Discovered in the 1990s, the ECS is a network of receptors and signaling molecules that works as the body’s master regulator, coordinating communication between major systems like the nervous, immune, cardiovascular, and digestive systems.

The roots of this discovery go back much further. CBD was first isolated in 1940 by American chemist Roger Adams, but it was Dr. Raphael Mechoulam, an Israeli organic chemist, who fully elucidated the chemical structure of CBD and identified its stereochemistry in the 1960s. His pioneering work not only opened the door to modern cannabinoid science but also earned him the title “Godfather of Cannabis Research.” It was this foundation that led to the identification of the endocannabinoid system itself decades later, revealing how cannabinoids interact with our physiology on a fundamental level.

The ECS is now widely recognized as a vital part of human biology, with extensive research supported by the National Institutes of Health. When functioning properly, the ECS acts like the conductor of an orchestra, ensuring every section plays in harmony. As we age, the system weakens. That imbalance is linked to inflammation, chronic pain, cognitive decline, sleep problems, and many other conditions associated with aging.

Mainstream medicine often addresses these issues with pharmaceutical band aids, dangerous and addictive drugs that treat symptoms rather than root causes. Lifestyle changes such as diet and exercise help, but they only partially support the ECS and do so slowly over time.

Hemp Derived CBD: A Game Changer for Aging

Here is where the science gets exciting. As the video explains, the ECS can be restored much more quickly with hemp derived CBD. Strengthening this system naturally helps the body regain balance, reducing pain, improving sleep, lowering stress, slowing disease progression, and even extending healthy lifespan.

It is not theoretical. One in five seniors is already using CBD to manage pain, arthritis, cancer symptoms, sleep disorders, Alzheimer’s, and more. Despite decades of research and acknowledgment from institutions like the National Institutes of Health, most physicians receive no training on the ECS. There are still no FDA standards for CBD products on the market. If that were the case for any other class of medicine, it would be considered malpractice.

The World Health Organization has confirmed CBD’s excellent safety profile and non addictive nature in its critical review report. The result is that millions of older Americans are suffering unnecessarily when a safe and natural solution exists.

Hemp derived CBD is a powerful first step in restoring balance to the endocannabinoid system, but it is only part of the picture. Research shows that full spectrum cannabis extracts, which include a broader range of cannabinoids and terpenes, can work even more effectively. Complete concentrated cannabis oil, containing the full spectrum of natural endocannabinoids, may deliver the most profound results for certain patients. Expanding access to these therapies will be essential if we want to unlock the full healing potential of this plant.

The Economic and Social Impact

The video cites a powerful figure. A PricewaterhouseCoopers analysis estimates that fully integrating cannabis into the healthcare system could save the United States nearly 64 billion dollars annually. These savings reflect reduced pharmaceutical dependency, fewer hospitalizations, improved chronic disease outcomes, and enhanced quality of life for aging Americans. You can read more about PwC’s research on healthcare innovation here.

It is a financial argument, but it is also a moral one. Why should our elders endure pain, anxiety, and cognitive decline when nature has given us tools to help them live longer, happier, and healthier lives?

A Call to Action: Finish What the Farm Bill Started

The message concludes by crediting the 2018 Farm Bill, championed by President Trump, for legalizing hemp and laying the groundwork for today’s CBD market. The Farm Bill was just the first step.

Now the call is for bold next moves.

Educate doctors about the endocannabinoid system
Include CBD under Medicare coverage
Provide clear federal standards for CBD quality and dosing

These steps would constitute the most significant senior health reform in modern history, one that would transform aging and cement a powerful legacy for any administration that makes it happen.

What This Means for Future Cannabis Medicine

For those of us who have been in the cannabis community for decades, this is not just another news story. It is a signal that our movement is winning. A conversation that was once criminalized and censored is now being amplified by the President of the United States on his own platform.

It means the science is undeniable. It means the truth can no longer be buried. It means the wall of prohibition is cracking, not just legally, but culturally, scientifically, and politically.

It also means that everything we have been fighting for at 420 Magazine since 1993, education, access, healing, and justice, is finally moving full steam ahead. The President Trump CBD Cannabis Science Truth Social moment is proof that science and policy are finally converging.